Cite
Two classes of protective antibodies against Pseudorabies virus variant glycoprotein B: Implications for vaccine design.
MLA
Li, Xiangdong, et al. “Two Classes of Protective Antibodies against Pseudorabies Virus Variant Glycoprotein B: Implications for Vaccine Design.” PLoS Pathogens, vol. 13, no. 12, Dec. 2017, pp. 1–19. EBSCOhost, https://doi.org/10.1371/journal.ppat.1006777.
APA
Li, X., Yang, F., Hu, X., Tan, F., Qi, J., Peng, R., Wang, M., Chai, Y., Hao, L., Deng, J., Bai, C., Wang, J., Song, H., Tan, S., Lu, G., Gao, G. F., Shi, Y., & Tian, K. (2017). Two classes of protective antibodies against Pseudorabies virus variant glycoprotein B: Implications for vaccine design. PLoS Pathogens, 13(12), 1–19. https://doi.org/10.1371/journal.ppat.1006777
Chicago
Li, Xiangdong, Fanli Yang, Xule Hu, Feifei Tan, Jianxun Qi, Ruchao Peng, Min Wang, et al. 2017. “Two Classes of Protective Antibodies against Pseudorabies Virus Variant Glycoprotein B: Implications for Vaccine Design.” PLoS Pathogens 13 (12): 1–19. doi:10.1371/journal.ppat.1006777.